Not only Zurampic is targeting 2 millions people but also different variation and combination with other drugs will be developed which there will be no need for krystexxa.
Name is Zurampic, developed by AstraZeneca. It is used for uncontrolled gout.
This will kill krystexxa. TW waisted $510m and favored his old friends.
Now, which law firm should I choose is required some R&D. Any idea?
Shorts will attack again and BRCD may see much lower prices.
they went to pick up some flowers.
GILD has 7 forward PE. Also, it has $26B cash and adding $5B cash per quarter.
Use Pennsaid 1% more or twice then it becomes 2%.
If any HZNP insider posts here then the whole company will be in trouble. I mean it will be worse than Hillary notes.
May be yes and may be not. Japan market opened green but it went red. The worst market is when it opens green but fade away to red.